Medchemexpress LLC Tivantinib | 905854-02-6 | 99.6% | C23H19N3O2 | 200 MG

Supplier:  Medchemexpress LLC HY50686200MG

Tivantinib is a highly selective, low-molecular-weight, and orally available c-Met tyrosine kinase inhibitor. It selectively inhibits c-Met activity in both cell-free and cell-based assays, leading to a dose-dependent loss of proliferative capacity or caspase-dependent apoptosis in c-Met-expressing cancer cell lines.

• Highly selective c-Met tyrosine kinase inhibitor
• Inhibits c-Met activity in cell-free and cell-based assays
• Causes dose-dependent loss of proliferative capacity or apoptosis in c-Met-expressing cancer cells
• Orally available
• Inhibits constitutive c-Met phosphorylation
• Inhibits HGF-induced c-Met phosphorylation

Catalog No. 50-003-58746